Xi'An International Medical Investment (000516.SZ) has received approval from the China Securities Regulatory Commission for its application to issue stocks to specific targets.
International Medical (000516.SZ) announced that on September 7, 2026, it received a reply from the China Securities Regulatory Commission regarding the approval of Xi'an International Medical Investment Co., Ltd.'s application for the registration of stock issuance to specific objects, agreeing to the company's registration application for issuing stocks to specific parties.
Xi'An International Medical Investment (000516.SZ) announced that on September 7, 2026, it received a reply from the China Securities Regulatory Commission regarding the approval of Xi'An International Medical Investment Co., Ltd.'s application for the registration of stock issuance to specific targets, agreeing to the company's application for the registration of stock issuance to specific targets.
Related Articles
FS.COM (03355) spent approximately HKD 1,533,600 to repurchase 36,900 shares on September 7.
LONGFOR GROUP (00960) achieved a total contract sales amount of 20.84 billion yuan in the first eight months.
Kangda New Materials (002669.SZ) plans to invest 425 million yuan in the construction project for wind turbine blade structural adhesive and vacuum infusion epoxy resin adhesive.
FS.COM (03355) spent approximately HKD 1,533,600 to repurchase 36,900 shares on September 7.
LONGFOR GROUP (00960) achieved a total contract sales amount of 20.84 billion yuan in the first eight months.
Kangda New Materials (002669.SZ) plans to invest 425 million yuan in the construction project for wind turbine blade structural adhesive and vacuum infusion epoxy resin adhesive.
RECOMMEND
